Local toxicity from local anesthetic polymeric microparticles

Anesthesia and Analgesia

Volumn 116, Issue 4, 2013, Pages 794-803

  McAlvin, J Brian ^a,b,c   Reznor, Gally ^b   Shankarappa, Sahadev A ^b,c   Stefanescu, Cristina F ^c   Kohane, Daniel S ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Laboratory for Biomaterials and Drug Delivery   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LIDOCAINE; MICROSPHERE; POLYGLYCOLIC ACID; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; LOCAL ANESTHESIA; MYOTUBE; NERVE BLOCK; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TISSUE REACTION;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CELL SURVIVAL; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; INJECTIONS; LACTIC ACID; LIDOCAINE; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; MUSCLE FIBERS, SKELETAL; NANOPARTICLES; NERVE BLOCK; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

EID: 84876670114     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31828174a7     Document Type: Article

References (53)

1. Tanaka PP, Torres MF, Tenorio SB. Analysis of the acute cytotoxic potential of bupivacaine and 50% enantiomeric excess bupivacaine (s75-r25) incorporated into microspheres in rat sciatic nerves. Rev Bras Anestesiol 2012;62:223-34
2. Le Corre P, Estebe JP, Clement R, Du Plessis L, Chevanne F, Ecoffey C, Le Verge R. Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep. Int J Pharm 2002;238:191-203
3. Castillo J, Curley J, Hotz J, Uezono M, Tigner J, Chasin M, Wilder R, Langer R, Berde C. Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology 1996;85:1157-66
4. Curley J, Castillo J, Hotz J, Uezono M, Hernandez S, Lim JO, Tigner J, Chasin M, Langer R, Berde C. Prolonged regional nerve blockade: injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996;84:1401-10
5. Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine. Chem Pharm Bull 1982;30:3719-27
6. Padera R, Bellas E, Tse JY, Hao D, Kohane DS. Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology 2008;108:921-8
7. Drager C, Benziger D, Gao F, Berde CB. Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. Anesthesiology 1998;89:969-79
8. Masters DB, Berde CB, Dutta SK, Griggs CT, Hu D, Kupsky W, Langer R. Prolonged regional nerve blockade by controlled release of local anesthetic from a biodegradable polymer matrix. Anesthesiology 1993;79:340-6
9. Boedeker BH, Lojeski EW, Kline MD, Haynes DH. Ultralongduration local anesthesia produced by injection of lecithin-coated tetracaine microcrystals. J Clin Pharmacol 1994;34:699-702
10. Richard BM, Ott LR, Haan D, Brubaker AN, Cole PI, Nelson KG, Ross PE, Rebelatto MC, Newton PE. The safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogs. Expert Opin Investig Drugs 2011;20:1327-41
11. ® (bupivacaine liposome injectable suspension) administered by peripheral nerve block in rabbits and dogs. J Drug Deliv 2012;2012:962101
12. Richard BM, Rickert DE, Newton PE, Ott LR, Haan D, Brubaker AN, Cole PI, Ross PE, Rebelatto MC, Nelson KG. Safety evaluation of EXPAREL (DepoFoam bupivacaine) administered by repeated subcutaneous injection in rabbits and dogs: species comparison. J Drug Deliv 2011;2011:467429
13. Grant GJ, Vermeulen K, Langerman L, Zakowski M, Turndorf H. Prolonged analgesia with liposomal bupivacaine in a mouse model. Reg Anesth 1994;19:264-9
14. Mowat JJ, Mok MJ, MacLeod BA, Madden TD. Liposomal bupivacaine: extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. Anesthesiology 1996;85:635-43
15. Richard BM, Rickert DE, Doolittle D, Mize A, Liu J, Lawson CF. Pharmacokinetic compatibility study of lidocaine with EXPAREL in Yucatan miniature pigs. ISRN Pharm 2011;2011:582351
16. Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552-9
17. ® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011;28:776-88
18. Masters DB, Domb AJ. Liposphere local anesthetic timed-release for perineural site application. Pharm Res 1998;15:1038-45
19. Jia X, Colombo G, Padera R, Langer R, Kohane DS. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 2004;25:4797-804
20. Kohane DS, Lipp M, Kinney RC, Lotan N, Langer R. Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine. Pharm Res 2000;17:1243-9
21. Kohane DS, Lipp M, Kinney RC, Anthony DC, Louis DN, Lotan N, Langer R. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. J Biomed Mater Res 2002;59:450-9
22. Suzuki R, Arai YC, Hamayasu K, Fujita K, Hara K, Yamaguchi T, Sasaguri S. Complex of branched cyclodextrin and lidocaine prolonged the duration of peripheral nerve block. J Anesth 2009;23:295-7
23. Karashima K, Taniguchi M, Nakamura T, Takasaki M, Matsuo K, Irikura M, Irie T. Prolongation of intrathecal and sciatic nerve blocks using a complex of levobupivacaine with maltosyl-betacyclodextrin in rats. Anesth Analg 2007;104:1121-8
24. Bragagni M, Maestrelli F, Mennini N, Ghelardini C, Mura P. Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-β- cyclodextrin on drug anesthetic efficacy. J Liposome Res 2010;20:315-22
25. Wang CF, Djalali AG, Gandhi A, Knaack D, De Girolami U, Strichartz G, Gerner P. An absorbable local anesthetic matrix provides several days of functional sciatic nerve blockade. Anesth Analg 2009;108:1027-33
26. Gerner P, Wang CF, Lee BS, Suzuki S, Degirolami U, Gandhi A, Knaack D, Strichartz G. The relationship between functional sciatic nerve block duration and the rate of release of lidocaine from a controlled-release matrix. Anesth Analg 2010;111:221-9
27. Benoit PW, Belt WD. Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine). J Anat 1970;107:547-56
28. Benoit PW, Belt WD. Some effects of local anesthetic agents on skeletal muscle. Exp Neurol 1972;34:264-78
29. Yagiela JA, Benoit PW, Buoncristiani RD, Peters MP, Fort NF. Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg 1981;60:471-80
30. Foster AH, Carlson BM. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg 1980;59:727-36
31. Brun A. Effect of procaine, carbocain and xylocaine on cutaneous muscle in rabbits and mice. Acta Anaesthesiol Scand 1959;3:59-73
32. Epstein-Barash H, Shichor I, Kwon AH, Hall S, Lawlor MW, Langer R, Kohane DS. Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci USA 2009;106:7125-30
33. Nouette-Gaulain K, Bringuier S, Canal-Raffin M, Bernard N, Lopez S, Dadure C, Masson F, Mercier J, Sztark F, Rossignol R, Capdevila X. Time course of mitochondrial metabolism alterations to repeated injections of bupivacaine in rat muscle. Can J Anaesth 2010;57:836-42
34. Hogan Q, Dotson R, Erickson S, Kettler R, Hogan K. Local anesthetic myotoxicity: a case and review. Anesthesiology 1994;80:942-7
35. Neuburger M, Breitbarth J, Reisig F, Lang D, Buttner J. Complications and adverse events in continuous peripheral regional anesthesia Results of investigations on 3, 491 catheters [in German]. Anaesthesist 2006;55:33-40
36. Pere P, Watanabe H, Pitkanen M, Wahlstrom T, Rosenberg PH. Local myotoxicity of bupivacaine in rabbits after continuous supraclavicular brachial plexus block. Reg Anesth 1993;18:304-7
37. Kohane DS, Smith SE, Louis DN, Colombo G, Ghoroghchian P, Hunfeld NG, Berde CB, Langer R. Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain 2003;104:415-21
38. Zimmer C, Piepenbrink K, Riest G, Peters J. Cardiotoxic and neurotoxic effects after accidental intravascular bupivacaine administration: therapy with lidocaine propofol and lipid emulsion [in German]. Anaesthesist 2007;56:449-53
39. Yamashita A, Matsumoto M, Matsumoto S, Itoh M, Kawai K, Sakabe T. A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg 2003;97:512-9
40. Selander D. Neurotoxicity of local anesthetics: animal data. Reg Anesth 1993;18:461-8
41. Colombo G, Langer R, Kohane DS. Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve. J Biomed Mater Res A 2004;68:651-9
42. Padera RF, Tse JY, Bellas E, Kohane DS. Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve 2006;34:747-53
43. Colombo G, Padera R, Langer R, Kohane DS. Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone. J Biomed Mater Res A 2005;75:458-64
44. Kohane DS, Langer R. Biocompatibility and drug delivery systems. Chem Sci 2010;1:441-6
45. Thalhammer JG, Vladimirova M, Bershadsky B, Strichartz GR. Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology 1995;82:1013-25
46. Maurice JM, Gan Y, Ma FX, Chang YC, Hibner M, Huang Y. Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways. Acta Pharmacol Sin 2010;31:493-500
47. Kohane DS, Yieh J, Lu NT, Langer R, Strichartz GR, Berde CB. A re-examination of tetrodotoxin for prolonged duration local anesthesia. Anesthesiology 1998;89:119-31
48. Barnet CS, Louis DN, Kohane DS. Tissue injury from tricyclic antidepressants used as local anesthetics. Anesth Analg 2005;101:1838-43
49. Miller RD. Miller's Anesthesia. 7th ed. Philadelphia: Churchill Livingstone/Elsevier, 2010
50. Chen PC, Kohane DS, Park YJ, Bartlett RH, Langer R, Yang VC. Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects. J Biomed Mater Res A 2004;70:459-66
51. Kohane DS, Plesnila N, Thomas SS, Le D, Langer R, Moskowitz MA. Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility. Brain Res 2002;946:206-13
52. Hoare T, Zurakowski D, Langer R, Kohane DS. Rheological blends for drug delivery. I. Characterization in vitro. J Biomed Mater Res A 2010;92:575-85
53. Patenaude M, Hoare T. Injectable, mixed natural-synthetic polymer hydrogels with modular properties. Biomacromolecules 2012;13:369-78